Home » News » R&D Trends » Curemark, VTT Molecular Sciences Institute collaborate

Curemark, VTT Molecular Sciences Institute collaborate

Tuesday, August 27, 2013

Curemark, a drug R&D company focused on neurological disorders, has entered into a collaborative research agreement with the VTT Molecular Sciences Institute (MSI), an independent, nonprofit research institute in Berkeley, Calif.

“Tapping into MSI’s expertise will deepen our knowledge of the full nature of our proprietary enzyme’s biological properties,” said Dr. Matthew Heil, Curemark’s chief scientific officer. “We expect this research will lead to multiple additional indications and formulation possibilities, which will benefit people with unmet medical needs.”

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!